Antimicrobial Agents

Scientists are currently engaged in a vigorous quest to discover novel classes of antibiotics capable of combating drug-resistant bacteria. They are also exploring the potential of synergistic drug combinations to effectively address challenging infections. Bacteriophage therapy, or phage therapy, is being extensively researched as an alternative treatment for antibiotic-resistant bacterial infections.

Additionally, research efforts have intensified in the area of antiviral drugs, particularly in response to recent outbreaks like COVID-19. Antimicrobial peptides (AMPs) are also under study as potential alternatives to traditional antibiotics. By the end of the session, participants will have gained comprehensive knowledge of the latest and most pertinent innovations and research developments in this field.

Related Conference of Microbiology